SOW
NBIX icon

State of Wyoming’s Neurocrine Biosciences NBIX Stock Holding History

State of Wyoming’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$156K Sell
924
-597
-39% -$88.6K 0.02% 1160
2026
Q1 		$200K Sell
1,521
-1,276
-46% -$169K 0.02% 945
2025
Q4 		$397K Sell
2,797
-190
-6% -$27.5K 0.04% 530
2025
Q3 		$419K Buy
2,987
+1,316
+79% +$178K 0.05% 433
2025
Q2 		$210K Buy
1,671
+695
+71% +$79.7K 0.03% 881
2025
Q1 		$108K Buy
+976
New +$124K 0.01% 1147
2024
Q4 		– Sell
-1,503
Closed -$173K – 1772
2024
Q3 		$173K Buy
1,503
+127
+9% +$17.4K 0.02% 805
2024
Q2 		$189K Buy
+1,376
New +$189K 0.03% 599
2024
Q1 		– Sell
-749
Closed -$98.7K – 1762
2023
Q4 		$98.7K Buy
749
+165
+28% +$19K 0.02% 982
2023
Q3 		$65.7K Buy
+584
New +$61.5K 0.01% 1134
2023
Q2 		– Sell
-1,866
Closed -$189K – 1706
2023
Q1 		$189K Buy
1,866
+110
+6% +$11.4K 0.06% 365
2022
Q4 		$210K Buy
1,756
+1,457
+487% +$171K 0.07% 310
2022
Q3 		$32K Buy
299
+241
+416% +$24.5K 0.02% 1168
2022
Q2 		$6K Buy
58
+14
+32% +$1.29K ﹤0.01% 1708
2022
Q1 		$4K Buy
44
+8
+22% +$678 ﹤0.01% 1673
2021
Q4 		$3K Sell
36
-3
-8% -$276 ﹤0.01% 1750
2021
Q3 		$4K Sell
39
-18
-32% -$1.7K ﹤0.01% 1114
2021
Q2 		$6K Buy
57
+30
+111% +$2.88K ﹤0.01% 1058
2021
Q1 		$3K Buy
+27
New +$2.83K ﹤0.01% 460

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State of Wyoming's NBIX Position: Q2 2026 in Review

State of Wyoming reduced its Neurocrine Biosciences (NBIX) stake by 39% in Q2 2026, selling an estimated $88.6K and leaving 924 shares worth $156K. The position accounts for 0.02% of the portfolio, ranked #1160.

State of Wyoming first reported a position in NBIX in Q1 2021 and has held it in 19 quarters since. The position peaked at $419K in Q3 2025. 772 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • State of Wyoming held 924 shares of Neurocrine Biosciences worth $156K as of Q2 2026.
  • State of Wyoming sold 597 Neurocrine Biosciences shares in Q2 2026, an estimated $88.6K.
  • Neurocrine Biosciences made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #1160 holding.
  • State of Wyoming first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 19 quarters since.
  • State of Wyoming's Neurocrine Biosciences position peaked at $419K in Q3 2025.
  • 772 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.